{"id":43979,"date":"2022-05-17T11:01:27","date_gmt":"2022-05-17T09:01:27","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/"},"modified":"2022-05-17T11:01:27","modified_gmt":"2022-05-17T09:01:27","slug":"hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/","title":{"rendered":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5583668\/hepatitis-b-virus-surface-antigen-drugs-in?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=r6zjzs&amp;utm_campaign=1700169+-+Hepatitis+B+Virus+Surface+Antigen+Drugs+in+Development+2022&amp;utm_exec=cari18prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe report provides in depth analysis on Hepatitis B Virus Surface Antigen (HBsAg) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by Indications, Stage of Development, Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases.\n<\/p>\n<p>\nAdditionally, the report analyses the pipeline products across relevant therapy areas under development and provides an overview of key players involved in Hepatitis B Virus Surface Antigen (HBsAg) targeted therapeutics development and features dormant and discontinued projects.\n<\/p>\n<p>\nThe report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.\n<\/p>\n<p>\n<strong>Report Scope<\/strong>\n<\/p>\n<ul>\n<li>\nThe report provides a snapshot of the Global therapeutic landscape for Hepatitis B Virus Surface Antigen (HBsAg)\n<\/li>\n<li>\nThe report reviews Hepatitis B Virus Surface Antigen (HBsAg) targeted therapeutics under development by companies and universities\/research institutes based on information derived from company and industry-specific sources\n<\/li>\n<li>\nThe report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages\n<\/li>\n<li>\nThe report features descriptive drug profiles for the pipeline products which includes, Product Description, Descriptive Mechanism of Action (MoA), Research and Development (R&amp;D) brief, Licensing and Collaboration details &amp; Other Developmental Activities\n<\/li>\n<li>\nThe report reviews key players involved in Hepatitis B Virus Surface Antigen (HBsAg) targeted therapeutics and enlists all their major and minor projects\n<\/li>\n<li>\nThe report assesses Hepatitis B Virus Surface Antigen (HBsAg) targeted therapeutics based on Mechanism of Action (MoA), Route of Administration (RoA) and Molecule Type\n<\/li>\n<li>\nThe report summarizes all the dormant and discontinued pipeline projects\n<\/li>\n<li>\nThe report reviews latest news and deals related to Hepatitis B Virus Surface Antigen (HBsAg) targeted therapeutics<\/p>\n<p>\n\u00a0\n<\/p>\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<ul>\n<li>\nTherapeutics Development\n<\/li>\n<li>\nProducts under Development by Stage of Development\n<\/li>\n<li>\nProducts under Development by Therapy Area\n<\/li>\n<li>\nProducts under Development by Indication\n<\/li>\n<li>\nProducts under Development by Companies\n<\/li>\n<li>\nProducts under Development by Universities\/Institutes\n<\/li>\n<li>\nTherapeutics Assessment<\/p>\n<ul>\n<li>\nAssessment by Mechanism of Action\n<\/li>\n<li>\nAssessment by Route of Administration\n<\/li>\n<li>\nAssessment by Molecule Type\n<\/li>\n<\/ul>\n<\/li>\n<li>\nCompanies Involved in Therapeutics Development\n<\/li>\n<li>\nDrug Profiles<br \/>\n<\/p>\n<ul>\n<li>\nProduct Description\n<\/li>\n<li>\nMechanism of Action\n<\/li>\n<li>\nR&amp;D Progress\n<\/li>\n<\/ul>\n<\/li>\n<li>\nDormant Products\n<\/li>\n<li>\nDiscontinued Products\n<\/li>\n<li>\nProduct Development Milestones\n<\/li>\n<li>\nFeatured News &amp; Press Releases\n<\/li>\n<\/ul>\n<p>\n<strong>List of Tables<\/strong>\n<\/p>\n<ul>\n<li>\nNumber of Products under Development by Stage of Development, 2022\n<\/li>\n<li>\nNumber of Products under Development by Therapy Areas, 2022\n<\/li>\n<li>\nNumber of Products under Development by Indication, 2022\n<\/li>\n<li>\nNumber of Products under Development by Companies, 2022\n<\/li>\n<li>\nProducts under Development by Companies, 2022\n<\/li>\n<li>\nNumber of Products under Investigation by Universities\/Institutes, 2022\n<\/li>\n<li>\nProducts under Investigation by Universities\/Institutes, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Mechanism of Actions, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Route of Administration, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Molecule Type, 2022\n<\/li>\n<li>\nPipeline by Company 1, 2022\n<\/li>\n<li>\nPipeline by Company 2, 2022\n<\/li>\n<li>\nPipeline by Company 3, 2022\n<\/li>\n<li>\nPipeline by Company XX, 2022\n<\/li>\n<li>\nDormant Products, 2022\n<\/li>\n<li>\nDiscontinued Products, 2022\n<\/li>\n<\/ul>\n<p>\n<strong>List of Figures<\/strong>\n<\/p>\n<ul>\n<li>\nNumber of Products under Development by Stage of Development, 2022\n<\/li>\n<li>\nNumber of Products under Development by Therapy Areas, 2022\n<\/li>\n<li>\nNumber of Products under Development by Top 10 Indications, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Mechanism of Actions, 2022\n<\/li>\n<li>\nNumber of Products by Routes of Administration, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Routes of Administration, 2022\n<\/li>\n<li>\nNumber of Products by Molecule Types, 2022\n<\/li>\n<li>\nNumber of Products by Stage and Molecule Types, 2022\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5583668\/hepatitis-b-virus-surface-antigen-drugs-in?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=r6zjzs&amp;utm_campaign=1700169+-+Hepatitis+B+Virus+Surface+Antigen+Drugs+in+Development+2022&amp;utm_exec=cari18prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/ijw62l<\/a>\n<\/p>\n<p>\n<strong>About ResearchAndMarkets.com<\/strong>\n<\/p>\n<p>\nResearchAndMarkets.com is the world&#8217;s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#105;&#x6c;&#116;&#x6f;&#58;&#x70;&#114;&#x65;&#115;&#x73;&#64;&#x72;e&#x73;e&#x61;r&#x63;h&#x61;n&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;&#101;&#x73;&#115;&#x40;&#114;&#x65;&#115;&#x65;&#97;&#x72;&#99;&#x68;&#97;&#x6e;&#100;&#x6d;&#97;&#x72;&#107;&#x65;&#116;&#x73;&#46;&#x63;&#111;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides in depth analysis on Hepatitis B Virus Surface Antigen (HBsAg) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-43979","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides in depth analysis on Hepatitis B Virus Surface Antigen (HBsAg) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-05-17T09:01:27+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Hepatitis B Virus Surface Antigen Drugs in Development 2022 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-05-17T09:01:27+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/\"},\"wordCount\":685,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220517005674\\\/en\\\/1458016\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/\",\"name\":\"Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220517005674\\\/en\\\/1458016\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-05-17T09:01:27+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220517005674\\\/en\\\/1458016\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220517005674\\\/en\\\/1458016\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Hepatitis B Virus Surface Antigen Drugs in Development 2022 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Hepatitis B Virus Surface Antigen Drugs in Development by Therapy Areas and Indications, Stages, MoA, RoA, Molecule Type and Key Players&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The report provides in depth analysis on Hepatitis B Virus Surface Antigen (HBsAg) targeted pipeline therapeutics. The report provides comprehensive information complete with Analysis by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-05-17T09:01:27+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 &#8211; ResearchAndMarkets.com","datePublished":"2022-05-17T09:01:27+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/"},"wordCount":685,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/","name":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg","datePublished":"2022-05-17T09:01:27+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220517005674\/en\/1458016\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/hepatitis-b-virus-surface-antigen-drugs-in-development-2022-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Hepatitis B Virus Surface Antigen Drugs in Development 2022 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43979","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=43979"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/43979\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=43979"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=43979"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=43979"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}